Numbing spray for ongoing migraine
Part of Brain & nervous system, Pain clinical trials.
This study tests whether a numbing spray applied inside the nose can relieve ongoing migraine pain. It may help people who have both migraines and sinus-like pressure or pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had headaches or facial pressure for at least 3 months
- You have at least 10 headache or facial pain days per month
- Your migraines come with sensitivity to light, trouble functioning, or nausea
- You have a smartphone that can run the study app
- You can avoid taking certain migraine medicines for 24 hours before each procedure visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a lidocaine infusion into an artery in the head can reduce severe chronic daily headaches. It is for people who have tried multiple treatments without enough relief.
This trial tests if a gentle nasal stimulation device can help prevent migraines. It is for adults with frequent migraines (at least 8 days per month).
This study tests a nasal spray called zavegepant to see how well it treats migraine attacks quickly. It may help people who have frequent migraines and need a fast-acting treatment.
This trial tests whether giving a numbing medicine (lidocaine) into a small artery in the face (the external carotid artery) can help people with hard-to-treat chronic migraines or persistent face/skull pain. It is for those who haven't found relief from standard treatments.
This study tests if injecting lidocaine (a numbing medicine) into an artery in the head can reduce chronic migraine pain. It may help people who have frequent migraines and are already getting a brain imaging test.
This study tests if a numbing spray applied inside the nose can help reduce headaches in people who have had a brain bleed from a ruptured aneurysm. The treatment targets a nerve cluster linked to headache pain.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.